Part 2/16:
Approximately 50 million U.S. adults suffer from mental illnesses, including depression, anxiety, and trauma-related conditions. The high prevalence and severity of these issues have propelled regulators and researchers alike to revisit and explore alternative therapies—particularly psychedelics, once stigmatized and marginalised in mainstream medicine.